Literature DB >> 17960812

Molding the sensory cortex: spatial acuity improves after botulinum toxin treatment for cervical dystonia.

Richard Walsh1, Michael Hutchinson.   

Abstract

Disorganization of sensory cortical somatotopy has been described in adult onset primary torsion dystonia (AOPTD). Although botulinum toxin type A (BTX-A) acts peripherally, some studies have suggested a central effect. Our primary hypothesis was that sensory cortical reorganization occurs after BTX-A treatment of AOPTD. Twenty patients with cervical dystonia and 18 healthy age-matched control patients had spatial discrimination thresholds (SDTs) measured at baseline and monthly for 3 months. Mean baseline SDT (+/-SD) was 1.75 +/-0.76 mm in the dystonia group, greater than the control group mean of 1.323 +/- 0.45 mm (P = 0.05). Mean control group SDT did not vary significantly over time. A transient improvement of 23% from baseline (P = 0.005) occurred in the dystonia group 1 month after injection, which did not positively correlate with changes in physician and patient ratings of torticollis severity. The presumed mechanism of SDT improvement is a modulation of afferent cortical inputs from muscle spindles. Society.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17960812     DOI: 10.1002/mds.21759

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  9 in total

1.  Dystonia: Five new things.

Authors:  Stella Marousi; Richard Grünewald
Journal:  Neurol Clin Pract       Date:  2015-10

2.  [Effect of botulinum toxin type B on residual limb sweating and pain. Is there a chance for indirect phantom pain reduction by improved prosthesis use?].

Authors:  K-U Kern; M Kohl; U Seifert; T Schlereth
Journal:  Schmerz       Date:  2012-04       Impact factor: 1.107

Review 3.  Molecular imaging of movement disorders.

Authors:  Karlo J Lizarraga; Alessandra Gorgulho; Wei Chen; Antonio A De Salles
Journal:  World J Radiol       Date:  2016-03-28

4.  The Use of Botulinum Toxin for Treatment of the Dystonias.

Authors:  Alfredo Berardelli; Antonella Conte
Journal:  Handb Exp Pharmacol       Date:  2021

Review 5.  The non-motor syndrome of primary dystonia: clinical and pathophysiological implications.

Authors:  Maria Stamelou; Mark J Edwards; Mark Hallett; Kailash P Bhatia
Journal:  Brain       Date:  2011-09-20       Impact factor: 13.501

6.  Spatial Discrimination Threshold Abnormalities are not Detected in a Pilot Study of DYT6 Dystonia Mutation Carriers.

Authors:  Andres F Deik; Sean O'Riordan; Marta San Luciano; Vicki L Shanker; Deborah Raymond; Susan B Bressman; Rachel Saunders-Pullman
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2012-09-17

7.  Cause or effect: Altered brain and network activity in cervical dystonia is partially normalized by botulinum toxin treatment.

Authors:  Stefan Brodoehl; Franziska Wagner; Tino Prell; Carsten Klingner; O W Witte; Albrecht Günther
Journal:  Neuroimage Clin       Date:  2019-03-26       Impact factor: 4.881

Review 8.  Central Effects of Botulinum Neurotoxin-Evidence from Human Studies.

Authors:  David Weise; Christopher M Weise; Markus Naumann
Journal:  Toxins (Basel)       Date:  2019-01-06       Impact factor: 4.546

Review 9.  The role of sensory information in the pathophysiology of focal dystonias.

Authors:  Antonella Conte; Giovanni Defazio; Mark Hallett; Giovanni Fabbrini; Alfredo Berardelli
Journal:  Nat Rev Neurol       Date:  2019-04       Impact factor: 42.937

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.